§ 01 Overview
Overview
Khavinson cartilage-derived tetrapeptide (from Sigumir). Proposed to stimulate chondrocyte proliferation and type-II collagen synthesis.
Khavinson lab. Limited Western replication.
§ 02 Mechanism
Mechanism of action
Cartalax is derived from cartilage extract. It's proposed to stimulate chondrocyte proliferation and type-II collagen synthesis in aging joints.
- 01Cartilage / joint support (Russian preclinical)
§ 03 Dosing
Dosing protocol
Standard Protocol
- Dose Range
- 5 – 10 mg per course
- Route
- SubQ
- Frequency
- Daily for 10–20 days
§ 04 Evidence
Evidence & research
Khavinson lab. Limited Western replication.
FDA Status
Not FDA-approved.
§ 06 News
In the news
2 articles from the last 12 months · updates hourly
Brittane’ Grant Earns Economic Development Certification, Named President of East End Historic District - The Black Chronicle
Brittane’ Grant Earns Economic Development Certification, Named President of East End Historic District The Black Chronicle
Igneo buys concession for Algarve’s A22 until 2030 - Portugal Resident
Igneo buys concession for Algarve’s A22 until 2030 Portugal Resident
§ 07 Sourcing
Sourcing & supply
Regulatory status
Authentic supply from international sources
Authentic product originates from specific international manufacturers, most commonly Russian pharmaceutical facilities for Khavinson bioregulators. RUO vendors selling the same name are typically Chinese-synthesized research vials, not the original product.
International · 2
Cosmic Nootropic
The most credible Russian / Khavinson source for US buyers. Sources authentic bioregulators through 'Peptides Company' (ex-NPCRIZ).
Rupharma
12+ year Russian pharmacy reseller. Reviews.io 4.84/5 (81+). Has a genuine US warehouse for common peptides.
Listings are informational, not endorsement. Verify credentials and flags against FDA and PCAB databases before purchasing. Full directory & how to verify →
§ 09 Safety
Safety & side effects
Side effects
- 01Limited data
Contraindications
None specified.
§ 10 Questions
Cartalax FAQ
- What is Cartalax?
- Khavinson cartilage-derived tetrapeptide (from Sigumir). Proposed to stimulate chondrocyte proliferation and type-II collagen synthesis. Cartalax is derived from cartilage extract. It's proposed to stimulate chondrocyte proliferation and type-II collagen synthesis in aging joints.
- What is Cartalax used for?
- Reported uses include cartilage / joint support (russian preclinical). Evidence strength is rated Preclinical — see the evidence section for detail.
- How is Cartalax dosed?
- Commonly referenced dosing is 5 – 10 mg per course, typically daily for 10–20 days, administered SubQ. This is educational reference only; consult a licensed clinician before use.
- What are the side effects of Cartalax?
- Commonly reported side effects include limited data. This list is not exhaustive.
- Is Cartalax legal?
- Authentic product originates from specific international manufacturers, most commonly Russian pharmaceutical facilities for Khavinson bioregulators. RUO vendors selling the same name are typically Chinese-synthesized research vials, not the original product. FDA status: Not FDA-approved..